N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide is a fluorinated aldehyde ADC linker designed for efficient bioorthogonal conjugation, providing enhanced stability and specificity in antibody-drug conjugate synthesis.
Structure of 1225588-22-6
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide is a chemical compound with promising applications in medicinal chemistry, particularly in the design and development of targeted therapies for cancer and other diseases. The structure of this molecule features a fluorophenoxyethyl group linked to a formylbenzamide, which plays a significant role in its bioactivity. The presence of a fluorine atom in the phenoxy group enhances the compound’s lipophilicity, which can improve its ability to cross cellular membranes and its overall bioavailability. This characteristic makes it a valuable candidate for the development of small molecule drugs.
One of the key applications of N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide is in cancer therapy. The compound's structure suggests it may interact with specific biological targets, including those involved in cancer cell proliferation and survival. It is hypothesized that the formyl group may facilitate binding to certain receptors or enzymes involved in the regulation of cancer cell growth. Additionally, the fluorophenoxyethyl side chain can increase the specificity of the compound toward certain tumor cells or tissues, improving its selective cytotoxicity while minimizing off-target effects. This makes it a potential candidate for development as an anticancer agent, especially in the treatment of solid tumors.
N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide may also have applications in the modulation of enzyme activity, particularly in relation to the inhibition of key enzymes involved in disease pathways. The formyl group and the fluorophenoxyethyl chain could interact with enzymes like kinases or proteases that are crucial for cell signaling and metabolic processes. By selectively inhibiting these enzymes, the compound could disrupt abnormal cellular functions, offering therapeutic potential in diseases characterized by dysregulated enzyme activity, such as cancer, autoimmune diseases, and inflammatory disorders. This property opens doors for its use as a scaffold for designing enzyme inhibitors.
Another promising application of this compound is in the development of molecular probes for research in drug discovery. The unique structure of N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide makes it a suitable candidate for use in studies exploring the mechanisms of action of small molecules in cellular systems. By attaching various reporter groups or fluorescent tags to the compound, researchers can use it to track the interaction of the drug with its target in real-time. This application could significantly aid in the optimization of drug candidates by providing insights into drug-receptor interactions and cellular uptake.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00523 | N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide | 1137575-49-5 | |
BADC-00532 | N-(2-(3-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225588-29-3 | |
BADC-00533 | N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225705-45-2 | |
BADC-00534 | N-(2-(3-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1225790-49-7 | |
BADC-00535 | N-(2-(4-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1225790-59-9 | |
BADC-00536 | N-(2-(2,6-Dimethylphenoxy)ethyl)-4-Formylbenzamide | 1225936-91-3 | |
BADC-00539 | N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide | 1225972-65-5 | |
BADC-00540 | N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide | 1225979-81-6 | |
BADC-00541 | N-(2-(Benzo[d][1,3]dioxol-5-yloxy)ethyl)-4-Formylbenzamide | 1226006-03-6 | |
BADC-00543 | N-(2-(3-Ethoxyphenoxy)ethyl)-4-Formylbenzamide | 1226006-55-8 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.